385 related articles for article (PubMed ID: 32962239)
1. Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962239
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
[TBL] [Abstract][Full Text] [Related]
3. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and AChE Inhibitory Activity of Novel Thiazolylhydrazone Derivatives.
Osmaniye D; Sağlık BN; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA; Turan G
Molecules; 2019 Jun; 24(13):. PubMed ID: 31261693
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors.
Xu Y; Jian MM; Han C; Yang K; Bai LG; Cao F; Ma ZY
Bioorg Med Chem Lett; 2020 Mar; 30(6):126985. PubMed ID: 32008906
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Altıntop MD; Gurkan-Alp AS; Ozkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 Aug; 346(8):571-6. PubMed ID: 23881696
[TBL] [Abstract][Full Text] [Related]
12. Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
Sahin Z; Ertas M; Bender C; Bülbül EF; Berk B; Biltekin SN; Yurttaş L; Demirayak Ş
Drug Dev Res; 2018 Dec; 79(8):406-425. PubMed ID: 30343499
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, molecular docking, dynamics simulations, and
Işık A; Çevik UA; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2022 Nov; 77(11-12):447-457. PubMed ID: 35599239
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors.
Yurttaş L; Kaplancıklı ZA; Özkay Y
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1040-7. PubMed ID: 22871134
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
[TBL] [Abstract][Full Text] [Related]
17. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
Hussain R; Ullah H; Rahim F; Sarfraz M; Taha M; Iqbal R; Rehman W; Khan S; Shah SAA; Hyder S; Alhomrani M; Alamri AS; Abdulaziz O; Abdelaziz MA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144820
[TBL] [Abstract][Full Text] [Related]
18. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's.
Sun ZQ; Tu LX; Zhuo FJ; Liu SX
Bioorg Med Chem Lett; 2016 Feb; 26(3):747-750. PubMed ID: 26783181
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
